-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
When Exactly Will Aurora Cannabis Stock’s Downtrend End?
Disappointing earnings from CannTrust Holdings and regulatory violations from Tilray hurt Aurora Cannabis stock. Investors must decide if it's time to buy or hold on this dip.
Aurora Cannabis Doubles Down on U.S. CBD Market
Among marijuana stocks, Aurora Cannabis stock has been doing some of the best work at making smart acquisitions and investing in the future.
Marijuana Legalization: The Next “Domino” May Be About to Fall
Summertime is downtime for a lot of occupations – and politics is no exception. But that’s not to say there are no new developments. For example…right now, a movement is quietly gathering steam in one southeastern state, and it’s not getting much attention in the usual media outlets.
Watch Cronos Stock Continue to Grow Over the Coming Weeks
The cannabis sector is poised to break out of the summer doldrums -- and CRON stock will lead the charge.
Major Headlines Mean Opportunities for Smart Investors
Last week was full of major headlines, Matt McCall takes a look.
Aurora Cannabis Shareholders Aren’t Happy
Aurora Cannabis share holders are not happy and they shouldn't be. A big part of the value of the company may be an illusion.
HCP, Inc. is a Way to Play Real Estate and Healthcare
I want to avoid recommending too many bearish trades while we wait for the market to recover. That's why I'm recommending a bullish trade on HCP, Inc. (NYSE:HCP), a real estate investment trusts (REIT) that serves the healthcare industry.
Canopy Growth Stock Is Not the Place for Near-Term Cannabis Refuge
Shares of Canopy Growth stock are battered and the company's path to profitability may take too long for some investors' liking.
Hexo Stock Needs Just Two Things to Move Higher
Hexo stock lies below the top tier in its industry, but it offers a solid home base and a partnership that may eventually take it higher.
Hexo’s Burn Rate Is Dangerously High
Hexo's acquisition of Newstrike is continuosly bleeding money, meaning HEXO stock will falter unless investors see clear signs of a turnaround.
Marijuana Stocks: Catch the Next Hot Pot Stock Before It ‘Jumps’
As legalization gets closer, the trickle of marijuana stocks uplisting to major exchanges could turn into a flood. And you can make a heck of a lot of money investing in the best pot stocks BEFORE they “jump.”
All Eyes Are on Canopy Growth’s Revenue
Canopy Growth (CGC) stock reports earnings after the bell. Can its numbers back up the ambition goal of its CEO to reach $1 billion in sales?
3 Reasons to Love Cronos Stock
CRON stock is not without its risks. But recent bullish commentary from Piper Jaffray highlights all the reasons long-term investors may need to take a closer look at Cronos.
An Unlikely Victim of the Cannabis Craze
From marijuana to sports betting to autonomous vehicles, here's the latest on the trends that can make you life-changing gains.
If You Like Hexo stock, This May Be A Good Time To Buy It
If you like HEXO stock, it may be time to look at getting in. After being oversold, it recently found support around the $4 level.
Don’t Mess With Canopy Growth Stock Until CGC Reports Earnings
Given the increased risks for bulls and bears, we can expect CGC stock to present a stronger trade after the earnings reaction, not before.
Molson Coors May Be the Only Thing Propping Up HEXO Stock
As I stated in July, the Truss partnership with Hexo is ready to go when the legalization of cannabis-infused drinks happens in October, and distribution rolls out in December after the required 60-day waiting period.
